These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000613-35 A double-blind, multi-centre, reference-controlled, randomised phase III study to compare the analgesic efficacy and tolerability of two buprenorphine transdermal systems using three different dosages... 2006-12-21 due-trials
Not reported 2006-004587-30 An open label, parallel group, Phase III clinical study in patients with advanced prostate cancer suitable for hormonal manipulation to demonstrate the non-inferiority of a new three-month Novosis Gos... 2008-04-28 due-trials
Ongoing 2008-000926-38 An open label, parallel group, multiple dose Phase III clinical study in patients with prostate cancer to demonstrate the non-inferiority of a new Novosis Leuprorelin 3.57 mg implant versus the refere... not-yet-due
Not reported 2008-001687-37 An open label, parallel group phase III clinical study in patients with prostate cancer to demonstrate the non-inferiority of a new Novosis Leuprorelin 10.72 mg implant versus the reference product Tr... 2009-03-17 due-trials
Not reported 2008-003592-48 A double-blind, multi-centre, reference-controlled, randomised Phase III study to compare the analgesic efficacy and tolerability of a buprenorphine transdermal system in two different application int... 2009-11-10 due-trials